ATR-IN-20
Product Specifications
Target
Others|||mTOR|||ATM/ATR
Related Pathways
DNA Damage/DNA Repair|||Others|||PI3K/Akt/mTOR signaling
Bioactivity
ATR-IN-20, a potent ATM/ATR inhibitor, showcases an IC50 value of 3 nM. It also exhibits inhibitory activity against mTOR with an IC50 of 18 nM, while maintaining selectivity over PI3K? (100 nM), ATM (100 nM), and DNA-PK (662 nM) . Additionally, ATR-IN-20 has an excellent pharmacokinetic profile with an oral bioavailability (F) of 30%, and demonstrates anticancer effects.
Smiles
C[C@@H]1COCCN1C2=NC(=NC3=C2CN(C3(C)C)C(=O)C4=CC(=CC=C4)S(=O)(=O)C)C5=C6C=CNC6=CC=C5
Molecular Formula
C29H31N5O4S
Molecular Weight
545.65
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
036956-ML490 100 µL
IKKB, phosphorylated (S672) (IKBKB, IKKB, Inhibitor of nuclear factor kappa-B kinase subunit beta, I-kappa-B kinase 2, Nuclear factor NF-kappa-B inhibitor kinase beta) (MaxLight 490) discontinued
Ask
View Details 
GTR15088542 1 Vial
Lentiviral human TREX2 shRNA (UAS) - Lentiviral human TREX2 shRNA (UAS) (100)
Ask
View Details